Case Study: Clerkenwell Health achieves global media coverage for psychedelics research with Pagefield

Clerkenwell Health secures coverage in 10+ outlets with Pagefield

Pagefield was hired by Clerkenwell Health, Europe’s first commercial clinical psychedelic trials facility, to support its UK launch. The challenge was to position the start-up as a leading voice and promote the UK as a global hub for psychedelics research, cutting through a busy media landscape to attract collaboration from international drug developers.

Pagefield devised clear media messaging focused on the patient benefits of psychedelic medicine and the news hook of Clerkenwell opening its unique facility. The vendor secured extensive high-profile coverage in outlets like The Times, Wall Street Journal, and The Guardian, which helped attract documentary interest and supported the company's Series A fundraise and new North American partnerships.

Clerkenwell Health